Cargando…

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy

The role of type 2 inflammation has been progressively associated with many diseases, including severe asthma, atopic dermatitis, nasal polyposis, eosinophilic granulomatosis with polyangiitis, and, recently, eosinophilic esophagitis. Despite this, the association between asthma and esophagitis is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bagnasco, Diego, Savarino, Edoardo Vincenzo, Yacoub, Mona-Rita, Braido, Fulvio, Candeliere, Maria Giulia, Giannini, Edoardo, Passalacqua, Giovanni, Marabotto, Elisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536373/ https://www.ncbi.nlm.nih.gov/pubmed/37765327 http://dx.doi.org/10.3390/pharmaceutics15092359

Ejemplares similares

Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Esophageal dysmotility in patients with eosinophilic esophagitis: pathogenesis, assessment tools, manometric characteristics, and clinical implications
por: Visaggi, Pierfrancesco, et al.
Publicado: (2022)

Clopidogrel-Induced Eosinophilic Colitis
por: Djahandideh Sheijani, Shirin, et al.
Publicado: (2023)

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art
por: Savarino, Vincenzo, et al.
Publicado: (2021)

Prevention Strategies for Esophageal Cancer—An Expert Review
por: Marabotto, Elisa, et al.
Publicado: (2021)

Impedance-detected Symptom Association and Number of Reflux Episodes as Pre-treatment Parameters That Predict Outcomes of Gastroesophageal Reflux Disease Patients
por: Savarino, Edoardo, et al.
Publicado: (2015)

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
por: Savarino, Edoardo, et al.
Publicado: (2016)

Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease
por: Savarino, Edoardo, et al.
Publicado: (2017)

Drugs for improving esophageal mucosa defense: where are we now and where are we going?
por: Savarino, Edoardo, et al.
Publicado: (2017)

COVID-19, Eosinophils, and Biologicals for Severe Asthma
por: Lombardi, Carlo, et al.
Publicado: (2022)

Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review
por: Marabotto, Elisa, et al.
Publicado: (2022)

Non-Invasive and Minimally Invasive Biomarkers for the Management of Eosinophilic Esophagitis beyond Peak Eosinophil Counts: Filling the Gap in Clinical Practice
por: Visaggi, Pierfrancesco, et al.
Publicado: (2023)

Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature
por: Ghisa, Matteo, et al.
Publicado: (2022)

Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease
por: Savarino, Edoardo, et al.
Publicado: (2014)

Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?
por: Varricchi, Gilda, et al.
Publicado: (2017)

Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose
por: Marabotto, Elisa, et al.
Publicado: (2022)

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data
por: Marabotto, Elisa, et al.
Publicado: (2020)

A multi-omic analysis reveals the esophageal dysbiosis as the predominant trait of eosinophilic esophagitis
por: Massimino, Luca, et al.
Publicado: (2023)

New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati, Marco, et al.
Publicado: (2019)

Optimal management of constipation associated with irritable bowel syndrome
por: Furnari, Manuele, et al.
Publicado: (2015)

Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults
por: Visaggi, Pierfrancesco, et al.
Publicado: (2021)

Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
por: Varricchi, Gilda, et al.
Publicado: (2016)

Gastrointestinal Tract Cancers, an Increasing Burden of the Modern Era: Epidemiology and Prevention
por: Kayali, Stefano, et al.
Publicado: (2023)

The Lyon Consensus: Does It Differ From the Previous Ones?
por: Ghisa, Matteo, et al.
Publicado: (2020)

Failure in Asthma Control: Reasons and Consequences
por: Braido, Fulvio
Publicado: (2013)

Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma
por: Bagnasco, Diego, et al.
Publicado: (2017)

Eosinophilic esophagitis in children: doubts and future perspectives
por: Cavalli, Elena, et al.
Publicado: (2019)

Lack of complications in patients with eosinophilic gastrointestinal diseases during SARS-CoV-2 outbreak
por: Savarino, Edoardo, et al.
Publicado: (2020)

Anti-IL5 Therapies for Severe Eosinophilic Asthma: Literature Review and Practical Insights
por: Menzella, Francesco, et al.
Publicado: (2020)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets
por: Racca, Francesca, et al.
Publicado: (2022)

Subsets of Eosinophils in Asthma, a Challenge for Precise Treatment
por: Novosad, Jakub, et al.
Publicado: (2023)

Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
por: Marasco, Giovanni, et al.
Publicado: (2023)

Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak
por: Savarino, Edoardo Vincenzo, et al.
Publicado: (2020)

Specific Therapy for T2 Asthma
por: Bagnasco, Diego, et al.
Publicado: (2022)

Psychological aspects in asthma: do psychological factors affect asthma management?
por: Baiardini, Ilaria, et al.
Publicado: (2015)

Plausible Role of Asthma Biological Modifiers in the Treatment of Eosinophilic Esophagitis
por: Olsen, Timothy C, et al.
Publicado: (2021)

Mechanistic Insights into Eosinophilic Esophagitis: Therapies Targeting Pathophysiological Mechanisms
por: Massironi, Sara, et al.
Publicado: (2023)

Novel impedance‐pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro‐oesophageal reflux disease according to Lyon Consensus
por: Ribolsi, Mentore, et al.
Publicado: (2021)

Use of the Platelet Count/Spleen Diameter Ratio for the Noninvasive Diagnosis of Esophageal Varices in Patients with Schistosomiasis
por: Agha, Adnan, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ilfm9j6797r03qemkgk9dookop